New Jersey-based NFI, a global leader in the transportation and logistics industry, has partnered with the non-profit organization MediSend International in an on-going humanitarian effort aimed at closing the widening gap between the availability of medical resources and the increasingly urgent healthcare needs of residents of developing countries. …..Click here to read more
NFI Partners with MediSend International to Deliver Medical Aid to Developing Nations
Posted by Dana in June 27th 2009
TARIS Biomedical Launches with $15 Million in Funding to Develop Innovative Drug-Device Therapies
Posted by Dana in June 27th 2009
TARIS Biomedical, a specialty pharmaceutical company pioneering the field of drug-device convergence for targeted therapies, launched and announced it has secured $15 million in Series A financing. Leading venture capital firms Flagship Ventures, Flybridge Capital Partners and Polaris Venture Partners co-led the investment in TARIS, which was founded by internationally renowned scientists from the Massachusetts Institute of Technology (MIT), Michael Cima, Ph.D. and Robert Langer, Ph.D., along with Christine Bunt, Chief Operating Officer and former executive with CombinatoRx, Merck & Co and Hoffmann La-Roche.
Related posts
Home Diagnostics Launches TRUEmanager Diabetes Management Software
Posted by Dana in June 26th 2009
Home Diagnostics, Inc. (NASDAQ:HDIX), a leading manufacturer and marketer of diabetes testing supplies, announced the launch of TRUEmanager Diabetes Management Software. The advanced reporting features and new user-friendly interface of TRUEmanager make it an essential tool for diabetes patients and healthcare professionals seeking long-term disease management.
Related posts
- Patients, Caregivers Can Learn to Manage Diabetes at Rite Aid Clinics June 23, 25 (0)
- VIAject Presentations at ADA Meeting Highlight Drug’s Mechanism of Absorption and Microvascular Effects (0)
- International Diabetes Study Establishes GlycoMark as Definitive Test for Blood Sugar Swings in Seemingly Well-Controlled Patients (0)
- Medtronic Highlights New Advances in Development of Closed-Loop System for Diabetes Management (0)
- VeroScience Presents Data on Newly FDA Approved Drug Cycloset at American Diabetes Association Annual Scientific Sessions (0)
Minnesota AIDS Project Recognizes National HIV Testing Day – Challenges Minnesotans to Know Their Status
Posted by Dana in June 26th 2009
In observance of National HIV Testing Day on June 27, organizations in cities across the United States are encouraging those at risk to access voluntary HIV testing and counseling to know his or her HIV status. The Minnesota AIDS Project, the leading source for HIV information and services in the state, offers risk assessments, information on transmission and prevention, live online chats, and testing referrals through its statewide AIDSLine service.
Related posts
- Biotech Leaders, Patient Advocates Highlight Cutting-Edge HIV/AIDS Therapies, Need for Next Generation Treatments (0)
- AIDS Patients with Serious Complications Benefit from Early Retroviral Use, Stanford Study Shows (0)
- SiDMAP, LLC Enters Japanese Market for Pharmaceutical Research Services with Two New Contracts for Metabolomics Testing and Biomarker Development (0)
- Novel Antipsychotic Drug for Patients with Schizophrenia (0)
Alliance HealthCare Services Receives National Award for Exceeding Patient Expectations
Posted by Dana in June 24th 2009
Alliance HealthCare Services, Inc. (NYSE:AIQ), a leading national provider of outpatient diagnostic imaging and radiation therapy services, has been awarded the Exceeding Expectations Award for 2008 by Avatar International, an industry leader in healthcare quality improvement services. Alliance also earned the award in 2007. …..Click here to read more
Related posts
- NFI Partners with MediSend International to Deliver Medical Aid to Developing Nations (0)
- MEDNAX to present at Jefferies & Company, Inc. Third Annual Healthcare Conference (0)
- Array BioPharma to Present at the Jefferies 3rd Annual Healthcare Conference (0)
- NPS Pharmaceuticals to Present at Jefferies Healthcare Conference (0)
- OSI Pharmaceuticals to Present at the Goldman Sachs 30th Annual Global Healthcare Conference on Tuesday, June 9, 2009 (0)
800th Implant of World’s Only Approved Total Artificial Heart Performed by Heart and Diabetes Center NRW
Posted by Dana in June 24th 2009
On June 12, the Heart and Diabetes Center NRW in Bad Oeynhausen, Germany, performed the 800th implant of the SynCardia temporary CardioWest Total Artificial Heart. The 60-year-old patient, who was suffering from biventricular failure, was listed in stable condition post-implant. …..Click here to read more
Related posts
- Direct Flow Medical Announces Fifth Patent Issuance of Their Unique Percutaneous Aortic Valve Technology (0)
- Disc Motion Technologies, the First Company to Commercialize the Posteriorly Total Motion Segment System for the Lumbar Spine, Announces the First Surgical Procedure Using Inlign Multi-Level Hybrid System (0)
- St. Jude Medical Announces European Approval of Its Newest Heart Failure Devices Which Enable More Efficient Implantation and Follow-up (0)
- TCF Bank Kenosha Branch Hosts a Bone Marrow and Blood Drive for Stephanie Ramirez (0)
- First Implant of a New-Generation CRT-D Device (0)
Patients, Caregivers Can Learn to Manage Diabetes at Rite Aid Clinics June 23, 25
Posted by Dana in June 23rd 2009
Select Rite Aid stores nationwide will host Diabetes Solutions Days on June 23 and 25 offering patients living with diabetes valuable health screenings and self-management solutions. Caregivers and patients alike can benefit from this free chance to get professional advice on the symptoms and treatments for diabetes as well as watching hands-on demonstrations. …..Click here to read more
Related posts
- Home Diagnostics Launches TRUEmanager Diabetes Management Software (0)
- VIAject Presentations at ADA Meeting Highlight Drug’s Mechanism of Absorption and Microvascular Effects (0)
- International Diabetes Study Establishes GlycoMark as Definitive Test for Blood Sugar Swings in Seemingly Well-Controlled Patients (0)
- Medtronic Highlights New Advances in Development of Closed-Loop System for Diabetes Management (0)
- VeroScience Presents Data on Newly FDA Approved Drug Cycloset at American Diabetes Association Annual Scientific Sessions (0)
State Stem Cell Agency Releases $3.9 Million Training Grant to Stanford
Posted by Dana in June 23rd 2009
Citing an easing of financial pressure, the governing board of the California Institute for Regenerative Medicine voted to release $40.6 million to fund 15 previously approved training programs. Of that total, $3.9 million will go to the Stanford University School of Medicine.
…..Click here to read more
Related posts
- Osiris Therapeutics to Present at Piper Jaffray Conference (0)
- NERI and ProMedica CRC Form Strategic Alliance to Support Phase I-IV Clinical Research Studies (0)
- Northfield Laboratories Announces Decision to Wind Down Business (0)
- BioTime CEO Dr. Michael West to Present at World Stem Cells & Regenerative Medicine Congress 2009 and Discuss New Cell Lines with Cartilage-Forming Potential (0)
- Stanford Researchers Receive $5.8 Million Grant from State Stem Cell Agency (0)
Dutch Ambulance Service First to Purchase ZOLL Integrated Automated Compression-Defibrillation System
Posted by Dana in June 22nd 2009
ZOLL Medical Corporation (Nasdaq GS: ZOLL), a manufacturer of resuscitation devices and related software solutions, announced that the ambulance service, RAV Gooi en Vechtstreek in Hilversum, The Netherlands, is the first EMS organization to equip its ambulances with a revolutionary new system that allows rescuers to defibrillate a heart without the need to stop chest compressions. …..Click here to read more
Related posts
NICE GUIDANCE GIVES CLINICIANS GO-AHEAD TO PRESCRIBE REVLIMID FOR TREATMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA
Posted by Dana in June 22nd 2009
Celgene Limited–The National Institute for Health and Clinical Excellence (NICE) has issued new guidance, recommending the use of REVLIMID (lenalidomide), in combination with dexamethasone, for the treatment of relapsed/refractory multiple myeloma. According to the guidance, REVLIMID should be prescribed in patients who have received two or more prior therapies. In accordance with this guidance, REVLIMID, an oral treatment, will now be made available for prescription through primary care trusts in England and Wales. …..Click here to read more
Related posts
Recent Articles
-
- NFI Partners with MediSend International to Deliver Medical Aid to Developing Nations
- TARIS Biomedical Launches with $15 Million in Funding to Develop Innovative Drug-Device Therapies
- Home Diagnostics Launches TRUEmanager Diabetes Management Software
- Minnesota AIDS Project Recognizes National HIV Testing Day – Challenges Minnesotans to Know Their Status
- Alliance HealthCare Services Receives National Award for Exceeding Patient Expectations
- 800th Implant of World’s Only Approved Total Artificial Heart Performed by Heart and Diabetes Center NRW
- Patients, Caregivers Can Learn to Manage Diabetes at Rite Aid Clinics June 23, 25
- State Stem Cell Agency Releases $3.9 Million Training Grant to Stanford
- Dutch Ambulance Service First to Purchase ZOLL Integrated Automated Compression-Defibrillation System
- NICE GUIDANCE GIVES CLINICIANS GO-AHEAD TO PRESCRIBE REVLIMID FOR TREATMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA
- Osiris Therapeutics to Present at Piper Jaffray Conference
- 8th INT’L BIO FORUM & BIO EXPO JAPAN: Strategy Against H1N1 Influenza
- TranSenda & Harvard Clinical Research Institute Announce Office-Smart Deployment
- MiCardia Announces First U.S. Implant
- June 23 DIA Sessions Chaired by SAFE-BioPharma Association
